alexa Risk Management Life Cycle Approach - Key Points
ISSN: 2329-6887

Journal of Pharmacovigilance
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

9th International Conference and Exhibition on Pharmacovigilance & Drug Safety
July 17-18, 2017 Munich, Germany

Essam Ghanem
Keyrus Biopharma, Belgium
Keynote: J Pharmacovigil
DOI: 10.4172/2329-6887-C1-025
Abstract
The health authorities’ activities are targeting public health protection from the harm of used medicines, emphasizing their role in medicines risk assessment. Such achievement requires optimization of their collaboration with industry, addressing criticalities. The interactions with the involved stakeholders have a pivotal role where transparency during assessment of medicines’ benefit–risk profile throughout its life cycle should be ensured. Structured benefit/risk assessment framework earlier in drug development is challenging for medicinal products approval that necessitate positive benefit-risk balance parameters. At the end, the key question is “Do the health authorities’ interactions with patients and healthcare professionals have a beneficial impact on the taken decision”?
Biography

Essam Ghanem is an experienced Physician and qualified person for pharmacovigilance with almost 25 years of experience in Clinical Research and Drug Development at academic institutes, pharmaceutical industry and clinical research organizations. He has eight years of working experience as EUQPPV and as Consultant Safety Physician in the pharmaceutical industry. He is the Founder of the pharmacovigilance consultation company Vigi-Care BVBA. Currently, he is Head of Drug Safety and Pharmacovigilance at Keyrus Biopharma.

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords